Tirzepatide price by dose
How tirzepatide pricing changes (or doesn't) across the 2.5–15 mg titration range, with links to a detailed cost page for each dose.
Tirzepatide price by dose (2026)
Compounded flat pricing is the same at every dose; brand-name self-pay varies. Pick your dose for a detailed breakdown.
| Dose | Compounded (NexLife) | Zepbound LillyDirect | Brand retail |
|---|---|---|---|
| 2.5 mg | $186 (flat) | $299 (Zepbound self-pay) | ~$1,086 retail |
| 5 mg | $186 | $399 | ~$1,086 |
| 7.5 mg | $186 | $449* | ~$1,086 |
| 10 mg | $186 | $449* | ~$1,086 |
| 12.5 mg | $186 | $449* | ~$1,086 |
| 15 mg | $186 | $449* | ~$1,086 |
*$449 requires refilling within LillyDirect's 45-day window; otherwise standard tiers ($599–$1,049) apply. Detailed per-dose pages: 2.5 mg · 5 mg · 7.5 mg · 10 mg · 12.5 mg · 15 mg.
Questions
Does tirzepatide cost more at higher doses?
Compounded flat-rate pricing is the same at every dose ($186/mo). Brand-name self-pay rises by dose unless you stay in LillyDirect's 45-day refill window. Compounded is not FDA-approved. See NexLife pricing
Which dose is the maintenance dose?
Maintenance is usually a higher dose (often 10–15 mg) chosen by your clinician after titration; see our maintenance cost guide.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.